Sunan gama gari: | Degarelix acetate |
Cas No.: | 214766-78-6 |
Tsarin kwayoyin halitta: | Saukewa: C82H103ClN18O16 |
Nauyin kwayoyin halitta: | 1632.28 g/mol |
Jeri: | Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-4-amino-Phe(L-hydroorotyl)-4-ureido- D-Phe-Leu-Lys(isopropyl)-Pro- D-Ala-NH2 acetate gishiri |
Bayyanar: | Farin foda |
Aikace-aikace: | Degarelix acetate magani ne da ake amfani dashi don magance ciwon daji na prostate. Yana cikin rukunin magungunan da ake kira gonadotropin-releasing hormone (GnRH) antagonists. Ba kamar GnRH agonists ba, wanda ya fara haɓaka samar da testosterone sannan kuma ƙananan testosterone, degarelix acetate kai tsaye yana toshe aikin GnRH, don haka rage matakan testosterone a cikin jiki. Ta hanyar rage matakan testosterone, degarelix acetate yana taimakawa rage ci gaban kwayoyin cutar kansar prostate. Ana yin allurar a ƙarƙashin fata sau ɗaya a wata. An nuna cewa Degarelix acetate yana da tasiri a cikin sauri rage matakan testosterone da kiyaye su a cikin kewayon da ake buƙata don maganin ciwon daji na prostate. Degarelix acetate wani zaɓi ne mai mahimmanci na jiyya ga maza masu fama da ciwon gurguwar ƙwayar cuta waɗanda ba za su iya ko ba sa so su yi simintin tiyata ko shan magungunan baka waɗanda ke rage matakan testosterone. Gabaɗaya ana jurewa da kyau, kuma illolin gama gari sun haɗa da halayen wurin allura, gumi, walƙiya mai zafi, da rage sha'awar sha'awa. Gabaɗaya, Degarelix acetate wani zaɓi ne mai inganci kuma tabbataccen magani don ciwon daji na prostate mai ci gaba, yana taimakawa sarrafa cutar da haɓaka ingancin rayuwar mai haƙuri. |
Kunshin: | Bag foil aluminum ko aluminum TIN ko kamar yadda abokin ciniki ta bukatun |
1 | ƙwararrun masu ba da kayayyaki don peptide APIs daga China. |
2 | 16 samar da Lines tare da isasshen babban samar iya aiki tare da m farashin |
3 | Ana samun GMP da DMF tare da mafi amintattun takardu. |
A: Ee, za mu iya tattarawa azaman buƙatun ku.
A: LC gani da TT a gaba biya lokaci fĩfĩta.
A: Ee, da fatan za a samar da ƙayyadaddun ingancin ku, za mu bincika tare da R&D ɗin mu kuma muyi ƙoƙarin daidaita ƙayyadaddun ingancin ku.